FOXP1 and diffuse large B-cell lymphoma: FOXP1 promoted gene expression underlying transition of the GCB-cell to the plasmablast—the transient B cell stage targeted in ABC-DLBCL transformation—by antagonizing pathways distinctive of GCB-DLBCL, including that of the GCB “master regulator,” BCL6.